Giovanna Poce

Pubblicazioni

Titolo	Pubblicato in	Anno
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment	PHARMACEUTICS	2022
Malaria transmission blocking compounds: a patent review	EXPERT OPINION ON THERAPEUTIC PATENTS	2022
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment	PHARMACEUTICS	2022
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2021
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2021
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes	ANTIOXIDANTS	2021
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy	SEMINARS IN CANCER BIOLOGY	2020
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis	PHARMACEUTICALS	2020
Overcoming drug resistance in TB: An update	FUTURE MICROBIOLOGY	2020
Novel therapies for glaucoma: a patent review (2013-2019)	EXPERT OPINION ON THERAPEUTIC PATENTS	2019
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development?	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS	2019
Novel pyrazole-containing compounds active against mycobacterium tuberculosis	ACS MEDICINAL CHEMISTRY LETTERS	2019
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects	ANTIOXIDANTS	2019
Development of MmpL3 inhibitors for tuberculosis treatment	Medicinal Chemistry approaches to tuberculosis and trypanosomiasis	2019
In vivo potent BM635 analogue with improved drug-like properties	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2018
Stimuli-responsive tannin–feIII hybrid microcapsules demonstrated by the active release of an anti-tuberculosis agent	CHEMSUSCHEM	2018
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents	CHEMISTRY OF HETEROCYCLIC COMPOUNDS	2017
MmpL3 is the flippase for mycolic acids in mycobacteria	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA	2017
Pharmaceutical salt of BM635 with improved bioavailability	EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES	2017
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2016

Pubblicazioni

Progetti di Ricerca